Biospective's clinical services team is comprised of experts in the design and management of imaging studies in clinical trials. Only Biospective provides such a broad range of cutting-edge MRI and PET biomarkers to maximize the sensitivity for detection of subtle structural and functional responses to treatment.

Our Clinical Services Include:
• Design of image acquisition protocols
• Site qualification and management
• Data management
• State-of-the-art image processing and quantitative analysis
• PET biodistribution studies
• CNS efficacy studies (Alzheimer's disease, multiple
   sclerosis, neuropsychiatric disease)

Alzheimer's Disease
• MRI
• Cortical thickness measurements
• Hippocampus and brain volumes
• Fully-automated morphometry (DBM, VBM)
• Functional MRI
• PET
• ¹⁸F-FDG for glucose metabolism
• Amyloid imaging
• Novel radiotracers